Sulggi Lee, MD, PhD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-735-5127
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0003-1560-2250 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CAB.A.06/1998Human Biology
    University of Southern California, Los Angeles, CAM.D., Ph.D.06/2007Medicine, Genetic Epidemiology
    Stanford Hospital & Clinics, Stanford, CAResidency06/2010Internal Medicine
    University of California San Francisco, San Francisco, CAFellowship07/2013Infectious Diseases
    Collapse Awards and Honors
    AIDS Clinical Trials Group (ACTG)2023  - 2024ACTG Cure Transformative Science Group Committee
    UCSF Center for AIDS Research Program (CFAR)2018  - 2018Excellence in Translational Science Award
    UCSF Center for AIDS Research (CFAR)2022  - 2024 Co-Director, CFAR Bioinformatics Core
    UCSF Women Physician Scientists Supergroup (WPSS)2020  - 2023Co-Founder, Executive Committee
    UCSF Single Cell Sequencing Group (SSIG)2018  - 2024Co-Founder, Director
    UCSF amfAR HIV Cure Institute2016  - 2020Clinical Core Director
    UCSF AIDS Research Institute (ARI)2015  - 2020Executive Committee

    Collapse Overview 
    Collapse Overview
    Sulggi Lee, MD PhD, is an Associate Professor of Medicine at the University of California, San Francisco (UCSF) and a faculty member in the Division of HIV, Infectious Diseases, and Global Medicine. She also serves as an attending physician at the San Francisco General Hospital inpatient infectious diseases and HIV consult service and in the Ward 86 HIV Clinic. After receiving her bachelor’s degree in human biology from Stanford University, she received her MD/PhD degree from the University of Southern California in genetic epidemiology. She completed her internal medicine residency training at Stanford Hospital and Clinics and Infectious Diseases fellowship training at UCSF.

    Dr. Lee’s research focuses on identifying underlying mechanisms of host-pathogen infectious diseases pathophysiology (e.g., HIV and COVID) leveraging patient samples from observational and clinical trials and applying high throughput genetic and immunologic assays. Her research includes studying host-specific drug responses to interventions using pharmacokinetic/ pharmacodynamic modeling as well as identifying genetic and immunologic signatures that predict unique clinical phenotypes.

    Dr. Lee is the PI of UCSF Treat Acute HIV cohort, which provides immediate antiretroviral therapy (ART) to newly diagnosed acute HIV individuals in the San Francisco Bay Area, PI of the Effect of Methamphetamine on Residual Latent HIV Disease (EMRLHD) cohort, Co-PI of the UCSF SCOPE HIV cohort, which includes over 2,500 HIV+ infected participants, and during the COVID-19 pandemic, she developed the acute COVID-19 Host Immune Response Pathogenesis (CHIRP) cohort. Her current funding includes an NIH NIAID R01 grant to explore the mechanisms by which interleukin-1 beta (IL-1β)/IL-6 signaling drives systemic inflammation during chronic treated HIV disease, an NIH NIDA R61/R33 award to evaluate the host immune response to methamphetamine use and how it contributes to HIV persistence, and a recent NIAID R56/R01 award to determine the host immune responses driving early viral control during acute treated HIV.
    Collapse Global Health Equity
    Collapse Mentoring

    Collapse Research 
    Collapse Research Activities and Funding
    Study of Acute HIV for Investigating Eradication Strategies (STAGES): The role of IL-10 and IFN signaling
    NIH/NIAID R01AI186774Nov 15, 2024 - Oct 31, 2029
    Role: Principal Investigator
    Methamphetamine Activation of Inflammasome and Altered immunity in HIV (MAIA) Study
    NIH R01DA062380Sep 30, 2024 - Jul 31, 2029
    Role: Principal Investigator (MPI)
    STudy of Acute HIV for investiGating Eradication Strategies (STAGES)
    NIH R56AI181653Aug 1, 2024 - Jul 31, 2025
    Role: Principal Investigator
    Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)
    NIH/NHLBI R01HL170600Jul 1, 2023 - Jun 30, 2028
    Role: Co-Investigator
    UCSF-Bay Area Center for AIDS Research
    NIH/NIAID 2 P30 AI027763-31Sep 1, 2022 - Aug 31, 2027
    Role: Co-Investigator, CFAR Bioinformatics Core Co-Director
    The heterogeneous HIV-expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound.
    NIH/NIAID P01AI169606May 1, 2022 - Apr 30, 2027
    Role: Co-Investigator
    MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
    NIH/NIAID R01 AI159260Jul 1, 2021 - Jun 30, 2026
    Role: Co-Investigator
    COVID-19 Host Immune Response Pathogenesis (CHIRP) Study
    Emergent Ventures at the Mercatus Center, George Mason University CA-0161832Aug 1, 2020 - Mar 31, 2024
    Role: Principal Investigator
    Evolutionary Dynamics of Viral Reservoir Cells
    Bill & Melinda Gates Foundation INV-002703Nov 1, 2019 - Oct 31, 2024
    Role: Co-Investigator
    AIDS and Cancer Specimen Resource
    NIH/NCI UM1 CA181255Sep 1, 2019 - Aug 31, 2024
    Role: Co-Principal Investigator
    Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease
    NIH R01AI143464Jun 1, 2019 - May 31, 2024
    Role: Principal Investigator
    Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
    NIH R33DA047024Aug 1, 2018 - May 31, 2026
    Role: Principal Investigator
    Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
    NIH R61DA047024Aug 1, 2018 - May 31, 2022
    Role: Principal Investigator
    Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection - Tissue-Based Studies
    Gilead Sciences IN-US-236-1354Jul 1, 2018 - Dec 31, 2024
    Role: Principal Investigator
    Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection
    VIiv Healthcare CA-0101618Apr 1, 2017 - Oct 31, 2024
    Role: Principal Investigator
    amfAR Institute for HIV Cure Research
    The Foundation for AIDS Research (amfAR) 109380-59-RGRLJan 1, 2016 - Dec 31, 2020
    Role: Co-Investigator; UCSF amfAR HIV Cure Institute Clinical Core Director
    A pharmacogenomics study of HIV latency: the role of PD-1 signaling
    NIH K23GM112526Aug 5, 2014 - Jul 31, 2019
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. HIV-SEQ REVEALS GLOBAL HOST GENE EXPRESSION DIFFERENCES BETWEEN HIV-TRANSCRIBING CELLS FROM VIREMIC AND SUPPRESSED PEOPLE WITH HIV. bioRxiv. 2024 Dec 20. Frouard J, Telwatte S, Luo X, Elphick N, Thomas R, Arneson D, Roychoudhury P, Butte AJ, Wong JK, Hoh R, Deeks SG, Lee SA, Roan NR, Yukl S. PMID: 39763963; PMCID: PMC11702770.
      View in: PubMed   Mentions:
    2. PP4.14 – 00024 HIV RNA+ cells from ART-suppressed PWH exhibit transcriptional profiles distinct from those during active viremia. Journal of Virus Eradication. 2024 Dec 1; 10:72. Frouard FJ, Telwatte TS, Luo LX, Elphick EN, Thomas TR, Arneson AD, Roychoudhury RP, Butte BA, Wong WJ, Hoh HR, Deeks DS, Lee LS, Yukl YS, Roan RN. .
      View in: Publisher Site   Mentions:
    3. Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease. Nat Commun. 2024 Nov 18; 15(1):9966. Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder S, Havlir D, Gandhi M, Henrich TJ, Hatano H, Wang J, Deeks SG, Lee SA. PMID: 39557853; PMCID: PMC11574060.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    4. Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19. Sci Transl Med. 2024 Nov 06; 16(772):eadq1789. Babcock BR, Kosters A, Eddins DJ, Donaire MSB, Sarvadhavabhatla S, Pae V, Beltran F, Murray VW, Gill G, Xie G, Dobosh BS, Giacalone VD, Tirouvanziam RM, Ramonell RP, Jenks SA, Sanz I, Lee FE, Roan NR, Lee SA, Ghosn EEB. PMID: 39504354.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1. J Clin Invest. 2024 Apr 23; 134(11). Whitehill GD, Joy J, Marino FE, Krause R, Mallick S, Courtney H, Park K, Carey J, Hoh R, Hartig H, Pae V, Sarvadhavabhatla S, Donaire S, Deeks SG, Lynch RM, Lee SA, Bar KJ. PMID: 38652564; PMCID: PMC11142743.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    6. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024 Feb; 25(2):218-225. Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young KC, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu S, Goldberg SA, Lee SA, Lynch KL, Kelly JD, Martin JN, Münch J, Deeks SG, Henrich TJ, Roan NR. PMID: 38212464; PMCID: PMC10834368.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    7. A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size. PLoS Pathog. 2023 Nov; 19(11):e1011114. Dwivedi AK, Gornalusse GG, Siegel DA, Barbehenn A, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Reppetti J, Vo PM, Levy CN, Roychoudhury P, Jerome KR, Hladik F, Henrich TJ, Deeks SG, Lee SA. PMID: 38019897; PMCID: PMC10712869.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. Assessing the associations between known genetic variants and substance use in people with HIV in the United States. PLoS One. 2023; 18(10):e0292068. Haas CB, Jordahl KM, Nance RM, Whitney BM, Wang L, Delaney JAC, Ruderman S, Jia T, Mathews WC, Saag MS, Lee SA, Napravnik S, Jacobson JM, Chander G, McCall EM, Moore RD, Mayer KH, Mukherjee S, Lee WJ, Crane PK, Crane H, Peter I, Lindström S. PMID: 37796845; PMCID: PMC10553320.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    9. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature. 2023 Aug; 620(7972):128-136. Augusto DG, Murdolo LD, Chatzileontiadou DSM, Sabatino JJ, Yusufali T, Peyser ND, Butcher X, Kizer K, Guthrie K, Murray VW, Pae V, Sarvadhavabhatla S, Beltran F, Gill GS, Lynch KL, Yun C, Maguire CT, Peluso MJ, Hoh R, Henrich TJ, Deeks SG, Davidson M, Lu S, Goldberg SA, Kelly JD, Martin JN, Vierra-Green CA, Spellman SR, Langton DJ, Dewar-Oldis MJ, Smith C, Barnard PJ, Lee S, Marcus GM, Olgin JE, Pletcher MJ, Maiers M, Gras S, Hollenbach JA. PMID: 37468623; PMCID: PMC10396966.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    10. Mild SARS-CoV-2 infection results in long-lasting microbiota instability. mBio. 2023 08 31; 14(4):e0088923. Upadhyay V, Suryawanshi RK, Tasoff P, McCavitt-Malvido M, Kumar RG, Murray VW, Noecker C, Bisanz JE, Hswen Y, Ha CWY, Sreekumar B, Chen IP, Lynch SV, Ott M, Lee S, Turnbaugh PJ. PMID: 37294090; PMCID: PMC10470529.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    11. Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size. AIDS. 2023 03 01; 37(3):477-488. Siegel DA, Thanh C, Wan E, Hoh R, Hobbs K, Pan T, Gibson EA, Kroetz DL, Martin J, Hecht F, Pilcher C, Martin M, Carrington M, Pillai S, Busch MP, Stone M, Levy CN, Huang ML, Roychoudhury P, Hladik F, Jerome KR, Kiem HP, Henrich TJ, Deeks SG, Lee SA. PMID: 36695358; PMCID: PMC9894159.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    12. Common and Divergent Features of T Cells from Blood, Gut, and Genital Tract of Antiretroviral Therapy-Treated HIV+ Women. J Immunol. 2022 04 01; 208(7):1790-1801. Xie G, Moron-Lopez S, Siegel DA, Yin K, Polos A, Cohen J, Greenblatt RM, Tien PC, Lee SA, Yukl SA, Roan NR. PMID: 35296537; PMCID: PMC8976750.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals. Front Immunol. 2022; 13:803417. George AF, Luo X, Neidleman J, Hoh R, Vohra P, Thomas R, Shin MG, Lee MJ, Blish CA, Deeks SG, Greene WC, Lee SA, Roan NR. PMID: 35154118; PMCID: PMC8829545.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    14. Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal. AIDS. 2022 01 01; 36(1):75-82. McMahon JH, Evans VA, Lau JSY, Symons J, Zerbato JM, Chang J, Solomon A, Tennakoon S, Dantanarayana A, Hagenauer M, Lee S, Palmer S, Fisher K, Bumpus N, Heck CJS, Burger D, Wu G, Zuck P, Howell BJ, Zetterberg HH, Blennow K, Gisslen M, Rasmussen TA, Lewin SR. PMID: 34586085.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. Elife. 2021 10 12; 10. Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene WC, Lee SA, Roan NR. PMID: 34636722; PMCID: PMC8545397.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCellsPHPublic Health
    16. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence. J Immunol. 2021 09 01; 207(5):1344-1356. Ma T, Ryu H, McGregor M, Babcock B, Neidleman J, Xie G, George AF, Frouard J, Murray V, Gill G, Ghosn E, Newell EW, Lee SA, Roan NR. PMID: 34389625; PMCID: PMC8763019.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    17. Tissue-specific differences in HIV DNA levels and mechanisms that govern HIV transcription in blood, gut, genital tract and liver in ART-treated women. J Int AIDS Soc. 2021 07; 24(7):e25738. Moron-Lopez S, Xie G, Kim P, Siegel DA, Lee S, Wong JK, Price JC, Elnachef N, Greenblatt RM, Tien PC, Roan NR, Yukl SA. PMID: 34235864; PMCID: PMC8264406.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    18. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. Cell Rep. 2021 07 20; 36(3):109414. Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee SA, Ghosn E, Lynch KL, Roan NR. PMID: 34260965; PMCID: PMC8238659.
      View in: PubMed   Mentions: 57     Fields:    
    19. Acute HIV at the Time of Initiation of Pre-exposure or Post-exposure Prophylaxis: Impact on Drug Resistance and Clinical Outcomes. J Acquir Immune Defic Syndr. 2021 06 01; 87(2):818-825. Johnson KA, Chen MJ, Kohn R, Sachdev D, Bacon O, Lee S, Cohen SE. PMID: 33512849.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    20. Novel RT-ddPCR assays for measuring the levels of subgenomic and genomic SARS-CoV-2 transcripts. Methods. 2022 05; 201:15-25. Telwatte S, Martin HA, Marczak R, Fozouni P, Vallejo-Gracia A, Kumar GR, Murray V, Lee S, Ott M, Wong JK, Yukl SA. PMID: 33882362; PMCID: PMC8105137.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    21. No detectable alloreactive transcriptional responses under standard sample preparation conditions during donor-multiplexed single-cell RNA sequencing of peripheral blood mononuclear cells. BMC Biol. 2021 01 20; 19(1):10. McGinnis CS, Siegel DA, Xie G, Hartoularos G, Stone M, Ye CJ, Gartner ZJ, Roan NR, Lee SA. PMID: 33472616; PMCID: PMC7816397.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    22. SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential. Cell Rep Med. 2020 09 22; 1(6):100081. Neidleman J, Luo X, Frouard J, Xie G, Gill G, Stein ES, McGregor M, Ma T, George AF, Kosters A, Greene WC, Vasquez J, Ghosn E, Lee S, Roan NR. PMID: 32839763; PMCID: PMC7437502.
      View in: PubMed   Mentions: 134     Fields:    
    23. Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection. PLoS Pathog. 2020 04; 16(4):e1008450. Hsiao F, Frouard J, Gramatica A, Xie G, Telwatte S, Lee GQ, Roychoudhury P, Schwarzer R, Luo X, Yukl SA, Lee S, Hoh R, Deeks SG, Jones RB, Cavrois M, Greene WC, Roan NR. PMID: 32353080; PMCID: PMC7192375.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    24. Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay. J Acquir Immune Defic Syndr. 2020 04 15; 83(5):530-537. Lee SA, Telwatte S, Hatano H, Kashuba ADM, Cottrell ML, Hoh R, Liegler TJ, Stephenson S, Somsouk M, Hunt PW, Deeks SG, Yukl S, Savic RM. PMID: 32168200; PMCID: PMC7286563.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    25. OP 4.2 Characterising ‘exceptional’ control among HIV elite controllers. Journal of virus eradication. 2019 Dec 1; 5:31. Peluso PM, Burbelo BP, Kumar KS, Munter MS, Hoh HR, Lee LS, Hunt HP, Rutishauser RR, Henrich HT, Deeks DS. .
      View in: Publisher Site   Mentions:
    26. 20 Kansui, an ingenol-containing herbal supplement, safely induced CD8, NK, and monocyte activation in three ART-suppressed SIVmac251-infected rhesus macaques. Journal of virus eradication. 2019 Jul 1; 5:12-13. Lee LS, Kesmy KK, Bacchetti BP, Hoh HR, Lifson LJ, Cary CD, Peterlin PB, Deeks DS, Hartigan-O’Connor HD. .
      View in: Publisher Site   Mentions:
    27. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS. 2019 04 01; 33(5):825-832. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. PMID: 30882490; PMCID: PMC7029629.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansPHPublic Health
    28. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV. 2018 Nov 29. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M. PMID: 30503324; PMCID: PMC6541554.
      View in: PubMed   Mentions: 32     Fields:    
    29. Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency. PLoS Pathog. 2018 11; 14(11):e1007357. Telwatte S, Lee S, Somsouk M, Hatano H, Baker C, Kaiser P, Kim P, Chen TH, Milush J, Hunt PW, Deeks SG, Wong JK, Yukl SA. PMID: 30440043; PMCID: PMC6237391.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    30. Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial. Clin Pharmacol Ther. 2019 03; 105(3):692-702. Lee SA, Elliott JH, McMahon J, Hartogenesis W, Bumpus NN, Lifson JD, Gorelick RJ, Bacchetti P, Deeks SG, Lewin SR, Savic RM. PMID: 30137649; PMCID: PMC6379104.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    31. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. AIDS Res Hum Retroviruses. 2018 11; 34(11):982-992. Chang JL, Lee SA, Tsai AC, Musinguzi N, Muzoora C, Bwana B, Boum Y, Haberer JE, Hunt PW, Martin J, Bangsberg DR, Kroetz DL, Siedner MJ. PMID: 29973058; PMCID: PMC6238612.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    32. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun. 2018 07; 71:108-115. Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, Shoptaw S, Flowers E, Dilworth SE, Pahwa S, Aouizerat BE. PMID: 29679637; PMCID: PMC6003871.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    33. PP4.10 HIV integrates in genes regulating cell cycle, DNA damage, and viral transport. Journal of virus eradication. 2017 Dec 1; 3:26. Lee LS, Haworth HK, Henrich HT, Deeks DS, Kiem KH. .
      View in: Publisher Site   Mentions:
    34. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. J Infect Dis. 2017 04 15; 215(8):1270-1274. Lee S, Byakwaga H, Boum Y, Burdo TH, Williams KC, Lederman MM, Huang Y, Tracy RP, Cao H, Haberer JE, Kembabazi A, Bangsberg DR, Martin JN, Hunt PW. PMID: 28329310; PMCID: PMC5853335.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    35. Efavirenz-metabolizing polymorphisms, viral suppression, and depression in HIV-infected individuals initiating antiretroviral therapy in southwestern Uganda. Open Forum Infectious Diseases. 2017 Jan 1; 4(suppl_1):s430-s431. Chang CJ, Lee LS, Hunt HP, Kroetz KD, Siedner SM. .
      View in: Publisher Site   Mentions:
    36. Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection. J Infect Dis. 2016 Oct 01; 214 Suppl 2:S44-50. Hunt PW, Lee SA, Siedner MJ. PMID: 27625430; PMCID: PMC5021241.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    37. The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough? EBioMedicine. 2016 Sep; 11:7-8. Lee SA, Deeks SG. PMID: 27515690; PMCID: PMC5049928.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    38. Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy. PLoS One. 2016; 11(8):e0160192. Lee SA, Bacchetti P, Chomont N, Fromentin R, Lewin SR, O'Doherty U, Palmer S, Richman DD, Siliciano JD, Yukl SA, Deeks SG, Burbelo PD. PMID: 27483366; PMCID: PMC4970722.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    39. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS. 2016 07 17; 30(11):1807-15. Lee SA, Mefford JA, Huang Y, Witte JS, Martin JN, Haas DW, Mclaren PJ, Mushiroda T, Kubo M, Byakwaga H, Hunt PW, Kroetz DL. PMID: 27088321; PMCID: PMC4925250.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    40. IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. J Clin Invest. 2016 07 01; 126(7):2745-56. Younes SA, Freeman ML, Mudd JC, Shive CL, Reynaldi A, Panigrahi S, Estes JD, Deleage C, Lucero C, Anderson J, Schacker TW, Davenport MP, McCune JM, Hunt PW, Lee SA, Serrano-Villar S, Debernardo RL, Jacobson JM, Canaday DH, Sekaly RP, Rodriguez B, Sieg SF, Lederman MM. PMID: 27322062; PMCID: PMC4922693.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    41. Immunologic profiles distinguish aviremic HIV-infected adults. AIDS. 2016 06 19; 30(10):1553-62. Ramirez CM, Sinclair E, Epling L, Lee SA, Jain V, Hsue PY, Hatano H, Conn D, Hecht FM, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 26854811; PMCID: PMC5679214.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    42. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. Lancet HIV. 2015 Dec; 2(12):e520-9. Elliott JH, McMahon JH, Chang CC, Lee SA, Hartogensis W, Bumpus N, Savic R, Roney J, Hoh R, Solomon A, Piatak M, Gorelick RJ, Lifson J, Bacchetti P, Deeks SG, Lewin SR. PMID: 26614966; PMCID: PMC5108570.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCellsCTClinical Trials
    43. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection. Clin Infect Dis. 2016 Feb 01; 62(3):392-6. Freeman ML, Mudd JC, Shive CL, Younes SA, Panigrahi S, Sieg SF, Lee SA, Hunt PW, Calabrese LH, Gianella S, Rodriguez B, Lederman MM. PMID: 26400999; PMCID: PMC4706630.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    44. Highlights from the Keystone Symposium on HIV Persistence 2015: 26-30 April 2015, Boston, Massachusetts, USA. J Virus Erad. 2015 Jul 01; 1(3):225-6. Lee SA. PMID: 27482417; PMCID: PMC4946746.
      View in: PubMed   Mentions:
    45. Bartonella quintana Aortitis in a Man with AIDS, Diagnosed by Needle Biopsy and 16S rRNA Gene Amplification. J Clin Microbiol. 2015 Aug; 53(8):2773-6. Lee SA, Plett SK, Luetkemeyer AF, Borgo GM, Ohliger MA, Conrad MB, Cookson BT, Sengupta DJ, Koehler JE. PMID: 26063867; PMCID: PMC4508458.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    46. IL-15 drives CD8 T cell cycling and differentiation in chronic HIV-1 infection (VIR6P.1162). The Journal of Immunology. 2015 May 1; 194(1_Supplement):149.2-149.2. younes ys, shive sc, Reynaldi RA, Freeman FM, Panigrahi PS, Estes EJ, Anderson AJ, Schacker ST, Davenport DM, McCune MJ, Hunt HP, Lee LS, Serrano-Villar SS, Canaday CD, Cameron CC, Sekaly SR, Rodriguez RB, Sieg SS, Lederman LM. .
      View in: Publisher Site   Mentions:
    47. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014 May; 10(5):e1004078. Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG. PMID: 24831517; PMCID: PMC4022662.
      View in: PubMed   Mentions: 314     Fields:    Translation:HumansCells
    48. Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J Infect Dis. 2014 Aug 01; 210(3):374-82. Lee SA, Sinclair E, Jain V, Huang Y, Epling L, Van Natta M, Meinert CL, Martin JN, McCune JM, Deeks SG, Lederman MM, Hecht FM, Hunt PW. PMID: 24585893; PMCID: PMC4110459.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    49. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One. 2014; 9(2):e89444. Lee SA, Sinclair E, Hatano H, Hsue PY, Epling L, Hecht FM, Bangsberg DR, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 24586783; PMCID: PMC3937334.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    50. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. BMC Med Genet. 2007 Dec 01; 8:72. Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO. PMID: 18053149; PMCID: PMC2219987.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    51. Chapter 40 Body weight, menopausal hormone therapy, and risk of breast cancer. Treatment of the Postmenopausal Woman. 2007 Jan 1; (J Natl Cancer Inst481972):569-578. Wu WA, Pearce PC, Spicer SD, Lee LS, Pike PM. .
      View in: Publisher Site   Mentions:
    52. Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda. J Infect Dis. 2006 Apr 15; 193(8):1160-3. Lee SA, Yeka A, Nsobya SL, Dokomajilar C, Rosenthal PJ, Talisuna A, Dorsey G. PMID: 16544257.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    53. Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort. Int J Cancer. 2006 Mar 01; 118(5):1285-91. Lee S, Kolonel L, Wilkens L, Wan P, Henderson B, Pike M. PMID: 16170777.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    54. An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer. 2005 Jun 06; 92(11):2049-58. Lee SA, Ross RK, Pike MC. PMID: 15900297; PMCID: PMC2361783.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    Sulggi's Networks
    Concepts (234)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (79)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-8-gc1ed69da on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.